Update on imatinib for gastrointestinal stromal tumors: duration of treatment
Mark Linch,1,2 Jeroen Claus,2 Charlotte Benson1 1Sarcoma Unit, Royal Marsden Hospital, 2Protein Phosphorylation Laboratory, Cancer Research UK London Research Institute, London, United Kingdom Abstract: Gastrointestinal stromal tumors (GISTs) are the most common sarcoma of the gastrointestinal tract...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-07-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/update-on-imatinib-for-gastrointestinal-stromal-tumors-duration-of-tre-a13846 |